drugset

drugset / Trial / NCT00044629

Combined Behavioral/Pharmacological Therapy for Insomnia

NCT00044629 ↗

Phase 2 Completed 162 enrolled Duke University National Institute of Mental Health (NIMH) · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.

Timeline

Start: 2001-09
Primary completion: —
Completion: 2006-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zolpidem	Small molecule	—	—

Indications